Zenara Pharma launches Paxlovid generic for COVID-19 in India EP News Bureau Sep 12, 2022 The drug reduces the risk of death or hospitalisation by 89 per cent
New generation of COVID vaccine shows promising results IANS Aug 30, 2022 As per a study, published in the journal 'EMBO Molecular Medicine,' the vaccine showed promising results in mice, and the…
US FDA orders Pfizer to test second Paxlovid course for rebound COVID patients Reuters Aug 22, 2022 The drugmaker must produce initial results of a randomised controlled trial of a second course of the antiviral by 30th September…
US study finds diabetes drug metformin may reduce COVID death risk by half Press Trust of India Aug 19, 2022 The widely available diabetes drug metformin may reduce the risk of emergency room visits, hospitalisation, and death from…
Antibody therapy less effective against new Omicron strains: Lancet IANS Jul 5, 2022 A team of researchers, including those from the German Primate Center (DPZ)-Leibniz Institute for Primate Research in Germany,…
FDA declines to authorise common antidepressant as COVID treatment Reuters May 17, 2022 The generic drug belongs to an old, widely-used class of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs)
US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with… EP News Bureau May 13, 2022 Olumiant is the first and only FDA-approved JAK inhibitor for the treatment of COVID-19 in certain hospitalised adults requiring…
IIT Madras-designed trial shows efficacy of Indomethacin drug in treating hospitalised mild and… EP News Bureau Apr 23, 2022 This research work promises a new line of treatment for mild COVID-19 infection as Indomethacin is an affordable drug and the…
US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults EP News Bureau Apr 4, 2022 If approved, Actemra/RoActemra would be the first US FDA-approved immunomodulator for the treatment of COVID-19 in hospitalised…
HIV drugs may curb COVID-19 risk Reuters Mar 29, 2022 Some new treatments for COVID-19 use protease inhibitors, which block the virus from multiplying